Navigation Links
Wound Management Technologies, Inc. Announces Negotiations to Acquire BioPharma Management Technologies, Inc.

FORT WORTH, Texas, Dec. 11 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), announced today that it is exploring a potential acquisition of BioPharma Management Technologies, Inc., a company that has recently launched the development of topical pain management products. "While we have been focusing this year on expanding market penetration of our CellerateRx(R) products, we also have been working to expand our current product portfolio. We believe that the science behind BioPharma's product development shows potential and creates market synergies with our current products," says Scott Haire, Wound Management Technologies' CEO. "We believe that BioPharma's products will provide a broad application across several medical specialities. We are not aware of any currently available products in the market that provide the benefits we expect BioPharma's unique formulation to deliver."

BioPharma is developing a topical pain management product targeting the growing pain management market place. "Based on our research, we believe that this product will provide a broad application across several medical specialities while supplying a good safety profile, expanded dosing range and flexibility, and should create and maintain a moist environment conducive to drug absorption and reduction of irritation at the application site. All year we have focused on Cellerate as a one-of-a-kind product and adding an additional company and product mix should make us a leader in the wound industry and related healthcare markets," states Scott Haire, CEO of Wound Management Technologies. "Also this should significantly increase our revenues in 2010 in all areas of wound care."

CellerateRx(R) is exclusively distributed by Wound Care Innovations, a subsidiary of Wound Management Technologies. It is a one-of-a-kind, patented, advanced wound care collagen product and is FDA cleared for acute and chronic wounds which include but are not limited to: diabetic ulcers, pressure ulcers stage I-IV, venous stasis ulcers, ulcers due to arterial insufficiency, surgical wounds, traumatic wounds, superficial wounds, and 1st and 2nd degree burns. "In 2008, the company has focused on providing additional evidence-based data and has been published in two major wound care publications as well as had a featured speaker at a major wound care conference. Our efforts in 2008 serve to boost customer confidence and will contribute to market success in 2009," states Cathy Bradshaw, President of Wound Care Innovations. "Adding BioPharma's future product mix has the potential to make us a leader in wound care and other medical management areas."

About Wound Management Technologies, Inc.:

Wound Management Technologies, Inc. (WNDM), with its corporate headquarters in Fort Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on the Company please visit the Company's Website at .

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

    Product Information                        Shareholder Relations
    Cathy Bradshaw                             Lucy Singleton
    President                                  Corporate Secretary
    954-315-9242                               817-820-7080

SOURCE Wound Management Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Life-Saving News for Battlefield Soldiers & Wounded Civilians
2. LifeNet Health Establishes The Skin & Wound Allograft Institute
3. Operation Mend Offers New Hope for Wounded Warriors
4. PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade(TM)
5. Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for Americas Returning Wounded Warriors Report Implementation
6. Patients should ask surgeons about using honey to heal wounds
7. The USO and Help Wounded Troops Stay Connected to Their Families
8. Trends in Treatment of Americas Wounded Warriors
9. Report Release: Trends in Treatment of Americas Wounded Warriors
10. Innocoll Receives Intends to Grant Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology
11. Randy Travis Participates in American Red Cross Holiday Card Program to Wounded Service Members
Post Your Comments:
(Date:10/13/2015)... ... , ... Symposium Chairman, Dr. Rod J. Rohrich is pleased to announce that ... March 2nd and 3rd, 2016. The annual meeting, along with the Dallas Rhinoplasty ... around the world. , Key topics at this year's event will include discussions on ...
(Date:10/13/2015)... ... October 13, 2015 , ... Relay (, a ... announced today a significant contract that will provide its award-winning private messaging solution ... on the growing success of its Relay program, IBX Wire™, which now has ...
(Date:10/13/2015)... ... October 13, 2015 , ... NavaFit Inc. today announced the launch of ... train with, participate in local fitness & sporting events, and stay motivated. ... high medical costs drive us to get more serious about fitness and wellness, individuals ...
(Date:10/13/2015)... Boston, MA (PRWEB) , ... October 13, 2015 , ... ... mortar of the body, including muscle, bone, and blood. But how much protein does ... more complicated than it might seem, according to the October 2015 issue of ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... Scientists in ... tissue biopsy in 18 patients with or without mesothelioma. Surviving Mesothelioma has just posted ... , The doctors from PhenoPath Laboratories in Seattle and the University of British Columbia ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... , Oct. 13, 2015  Data Science Automation (DSA), ... opening of a new branch office in the ... DSA,s presence in Europe . The decision ... increasing demand for local support of customers in the medical ... Ph.D., DSA,s UK Branch Manager. "We have had tremendous success ...
(Date:10/13/2015)... -- SeraCare Life Sciences, a leading partner to global in ... medicine business unit has launched its second product in ... (NGS)-based tumor profiling assays.  The Seraseq TM Solid ... mutations in key oncogenes and tumor suppressor genes as ... is offered at five additional allele frequencies. ...
(Date:10/13/2015)... , Oct. 13, 2015  Graduate students across ... and medical research, will soon have the opportunity ... care – the drug discovery and development process. ... has collaborated with 10 leaders from academic institutions ... Medicines: The Process of Drug Development."  Lilly will ...
Breaking Medicine Technology: